Corneal Collagen Cross-linking in a Prepubescent 10-Year-Old Girl with Aggressive Keratoconus

Abbondanza, Marco; Guidobaldi, Margherita

doi:10.5005/jp-journals-10025-1101

Cited by 1 publication

(1 citation statement)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There is also an ongoing debate on the validity of transepithelial corneal cross-linking, a technique that gives less discomfort to the patient, but is also generally regarded as less effective [6]. The latter has been confirmed in the treatment of pediatric patients with KC [7,8]. We have been performing CXL since 2005 and our experience brought us to the same conclusion.…”

Section: Discussionmentioning

confidence: 64%

Peripheral corneal cross-linking (P-CXL) for ultrathin corneas with severe keratoconus: a new technique

Abbondanza¹,

Felice²,

Abbondanza³

2017

Vestn. oftal'mol.

View full text Add to dashboard Cite

Corneal cross-linking (CXL) is aimed at halting the progression of keratoconus and is widely considered to be the golden standard in its treatment. It is usually contraindicated, however, in patients with corneal thickness of less than 400 µm, leaving the ophthalmic surgeon no option, but to perform transepithelial CXL (epi-on), usually regarded as less effective. We report a novel approach for ultrathin corneas with severe keratoconus - peripheral corneal cross-linking (P-CXL), in which corneal epithelium is still removed but the apex of the cornea is left untouched. Hypo-osmolar riboflavin solution is used as well. P-CXL was performed on a remarkably developed stage IV keratoconus with the thinnest pachymetry of 215 µm, Kmax of 88.1 D and astigmatism of 11.2 D. Four months after P-CXL, the thinnest pachymetry increased by 42 µm, Kmax decreased by 1.4 D, and astigmatism also decreased by 3.2 D.

show abstract

Section: Discussionmentioning

confidence: 64%